Biohaven BHVN Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss.
The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biohaven's debt securities, available-for-sale, amortized cost, after allowance for credit loss.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Biohaven's debt securities, available-for-sale, amortized cost, after allowance for credit loss?
- Biohaven (BHVN) reported debt securities, available-for-sale, amortized cost, after allowance for credit loss of $150.53M in Q1 2026.
- How has Biohaven's debt securities, available-for-sale, amortized cost, after allowance for credit loss changed year-over-year?
- Biohaven's debt securities, available-for-sale, amortized cost, after allowance for credit loss decreased by 32.9% year-over-year, from $224.29M to $150.53M.
- What is the long-term trend for Biohaven's debt securities, available-for-sale, amortized cost, after allowance for credit loss?
- Over 3 years (2022 to 2025), Biohaven's debt securities, available-for-sale, amortized cost, after allowance for credit loss has grown at a -28.4% compound annual growth rate (CAGR), from $310.51M to $114.11M.